Home › India's Ranbaxy gets FDA approval for Novartis's Diovan generic
 

Keywords :   


India's Ranbaxy gets FDA approval for Novartis's Diovan generic

2014-06-27 10:50:23| Chemicals - Topix.net

India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its India facilities dented investor sentiment.

Tags: approval generic fda indias

Category:Chemicals

Latest from this category

All news
26.11ROSS VersaMix Multi Shaft Mixers are for Complex Formulations
26.11PPG Completes Sale of Silicas Products Business to QEMETICA
26.11¦nie¿ka Among Leaders of Sustainable Development in Poland
26.11Solvay Unveils Climate and Water Projects in Brazil with HRH Princess Astrid of Belgium
25.11PPG Recognized in Newsweeks Americas Greenest Companies List
25.11Axalta Wins Another Distinguished R&D 100 Award for Innovation
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
Chemicals »
26.11BG
26.11 DVD 9
26.11Happy2024 LAST BIG
26.111-21
26.11A-68507
26.11160cm
26.11stray kids GO yes24
26.11 mark borthwick whats bummer zine edition
More »